National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

combretastatin A4 analogue AVE8062
A synthetic water-soluble analogue of combretastatin A4, derived from the South African willow bush (Combretum caffrum), with potential vascular-disrupting and antineoplastic activities. Combretastatin A4 analogue AVE8062 binds to the colchicine binding site of endothelial cell tubulin, inhibiting tubulin polymerization and inducing mitotic arrest and apoptosis in endothelial cells. As apoptotic endothelial cells detach from their substrata, tumor blood vessels collapse; the acute disruption of tumor blood flow may result in tumor necrosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code names:AC7700
AVE8062



Previous:colchicine, collagen/aloe vera/vitamin E/lidocaine topical hydrogel, colloidal gold-bound tumor necrosis factor, Colprosterone, Combidex
Next:combretastatin A4 phosphate, Compound 42, conatumumab, Concerta, conjugated estrogens

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov